Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
暂无分享,去创建一个
Nadav Davidovitch | Ran D. Balicer | Itamar Grotto | R. Balicer | I. Grotto | N. Davidovitch | M. Huerta | Michael Huerta
[1] J. Oxford,et al. Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] UK stocks up on antiviral drug to tackle flu outbreak , 2005, BMJ : British Medical Journal.
[3] M. Meltzer,et al. The economic impact of pandemic influenza in the United States: priorities for intervention. , 1999, Emerging infectious diseases.
[4] R. Balicer,et al. Tackling the next influenza pandemic , 2004, BMJ : British Medical Journal.
[5] R. Webster,et al. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. , 2000, Antiviral research.
[6] J. Fleiss,et al. The measurement of interrater agreement , 2004 .
[7] N E Breslow,et al. Elementary methods of cohort analysis. , 1984, International journal of epidemiology.
[8] A. Monto,et al. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. , 1999, JAMA.
[9] S. Lazzari,et al. Avian influenza and influenza pandemics. , 2004, Bulletin of the World Health Organization.
[10] A. Sutton,et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials , 2003, BMJ : British Medical Journal.
[11] P. Ward,et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. , 2003, Archives of internal medicine.
[12] World is ill-prepared for "inevitable" flu pandemic. , 2004, Bulletin of the World Health Organization.
[13] A. Nizam,et al. Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.
[14] C. DesRoches,et al. The public's response to severe acute respiratory syndrome in Toronto and the United States. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] F. Hayden,et al. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. , 1989, The New England journal of medicine.
[16] L. Huson,et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. , 1999, The New England journal of medicine.
[17] John J. Treanor,et al. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza , 2000 .
[18] H. Oshitani,et al. Detection of Amantadine-Resistant Influenza A Virus Strains in Nursing Homes by PCR-Restriction Fragment Length Polymorphism Analysis with Nasopharyngeal Swabs , 2002, Journal of Clinical Microbiology.
[19] C. Perry,et al. Oseltamivir , 2012, Drugs.
[20] WHO consultation on priority public health interventions before and during an influenza pandemic, Geneva, 16-18 March 2004. , 2004, Releve epidemiologique hebdomadaire.